BAVENCIO

Google image searchProduct monograph

Active ingredient

avelumab, 20 MG/ML

DIN: 02469723

Dosage form(s): SOLUTION

Route(s) of administration: INTRAVENOUS

Description: SINGLE USE VIAL

Schedule: Prescription / Schedule D

Company: EMD SERONO, A DIVISION OF EMD INC., CANADA

Date: 18-DEC-2017

ATC:

Search on Google